Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that ...

"Sickle cell disease is a devasting disorder that affects approximately 100,000 people in the U.S., leading to anemia, severe ...

By 2025, it is estimated that the worldwide period orthobiologics market will have an estimate of around USD 6,414.4 million.

U.S. President Donald Trump (79) made headlines by revealing his medical examination results. Breaking the prejudice that his ...

SCOTTSDALE, AZ, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- R3 Stem Cell, the global leader in regenerative therapies, ...

A boy who was told on his 16th birthday that the cancer he had been free from for 18 months had returned and spread to his ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight - without causing nausea ...

In the phase 1 trial, the researchers used donated stem cells (taken from early-stage embryos ... Given the success of the phase 1 trial, the U.S. Food and Drug Administration (FDA) has granted ...

A stem cell–based therapy initially developed at Memorial Sloan ... Based on these preliminary results, the U.S. Food and Drug Administration (FDA) has given approval to proceed directly to a phase 3 ...

While food availability is the obvious trigger for the change ... and showed that the metabolite accelerated the differentiation of stem cells into cells that will become the placenta.